Neumora (NMRA) analyst forecast and price target
Analyst forecast
Consensus of 9 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Outperform | $5.00 from $7.00 | Jul 13, 2026 |
| Mizuho | Maintained | Outperform | $4.00 from $6.00 | Jun 18, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 from $18.00 | Jun 16, 2026 |
| Needham | Maintained | Buy | $5.00 from $8.00 | Jun 16, 2026 |
| Needham | Maintained | Buy | $8.00 | Mar 31, 2026 |
| Guggenheim | Maintained | Buy | $14.00 | Mar 31, 2026 |
| William Blair | Upgraded | Market Perform → Outperform | — | Feb 17, 2026 |
| Leerink Partners | Initiated Coverage | Outperform | $8.00 | Jan 12, 2026 |
| RBC Capital | Upgraded | Sector Perform → Outperform | $7.00 from $4.00 | Dec 1, 2025 |
| Stifel | Maintained | Hold | $3.00 from $2.00 | Nov 17, 2025 |
| Needham | Maintained | Buy | $8.00 from $6.00 | Oct 28, 2025 |
| Guggenheim | Upgraded | Neutral → Buy | $14.00 | Oct 27, 2025 |
| JP Morgan | Downgraded | Neutral → Underweight | — | Sep 16, 2025 |
| Mizuho | Maintained | Outperform | $5.00 from $4.00 | Jul 16, 2025 |
| Needham | Maintained | Buy | $5.00 | May 13, 2025 |
| Needham | Maintained | Buy | $5.00 | Apr 10, 2025 |
| B of A Securities | Downgraded | Buy → Underperform | $1.00 from $7.00 | Apr 2, 2025 |
| Guggenheim | Downgraded | Buy → Neutral | — | Mar 10, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 | Mar 7, 2025 |
| Stifel | Downgraded | Buy → Hold | $2.00 from $6.00 | Mar 7, 2025 |
Frequently asked questions
What is the price target for NMRA stock?
The average 12-month analyst price target for Neumora (NMRA) is $5.25, with a high estimate of $7.00 and a low of $4.00, across 4 analysts.
Is NMRA a buy, sell, or hold?
Analysts covering Neumora currently average a Buy rating: 7 buy, 1 hold and 1 sell, from 9 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for NMRA?
The average price target of $5.25 implies 288.89% upside from the last price of $1.35.
What is the latest analyst rating on NMRA?
On Jul 13, 2026, RBC Capital maintained Neumora at Outperform with a price target of $5.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.